Daria Andreeva

Daria Andreeva

Auto-generated profile, based on publicly available information

Daria Andreeva

Almazov National Medical Research Centre, Ministry of Health of the Russian Federation, 197341, Saint-Petersburg

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Cardiology Research
Verified
Journal Article
Open access
PDF file
EPEkaterina Podyacheva
Ekaterina Podyacheva
TSTatiana Shmakova
Tatiana Shmakova
EKEkaterina Kushnareva
Ekaterina Kushnareva
AOAnatoliya Onopchenko
Anatoliya Onopchenko
MMMikhail Martynov
Mikhail Martynov
YTYana Toropova
Yana Toropova
Modeling Doxorubicin-Induced Cardiomyopathy With Fibrotic Myocardial Damage in Wistar Rats

25 March 2022 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
ASArtem Sinegubov
Artem Sinegubov
DADaria Andreeva
Daria Andreeva
NBNikita Burzak
Nikita Burzak
MVMaria Vasyutina
Maria Vasyutina
LMLada Murashova
Lada Murashova
VDVyacheslav Dyachuk
Vyacheslav Dyachuk
This review describes the heterogeneity of peripheral glial cell populations, from the emergence of Schwann cells (SCs) in early development, to their involvement, and that of their derivatives in adult glial populations. We focus on the origin of the first glial precursors from neural crest cells (NCCs), and their ability to differentiate into several cell types during development. We also discuss the heterogeneity of embryonic glia in light of the latest data from genetic tracing and transcriptome analysis. Special attention has been paid to the biology of glial populations in adult animals, by highlighting common features of different glial cell types and molecular differences that modulate their functions. Finally, we consider the communication of glial cells with axons of neurons in normal and pathological conditions. In conclusion, the present review details how information available on glial cell types and their functions in normal and pathological conditions may be utilized in the development of novel therapeutic strategies for the treatment of patients with neurodiseases.

6 November 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LBLízia Branco
Lízia Branco
TLThomas Lautenschlager
Thomas Lautenschlager
DADaria Andreeva
Daria Andreeva
ZYZeynep Yentür
Zeynep Yentür
FCFrancesco Castagnetti
Francesco Castagnetti
SMSimone Mayer
Simone Mayer
Summary: Neural organoids are three-dimensional stem cell-derived models widely used to study brain development and model disease. Brightfield imaging offers a non-invasive readout of their growth and morphology, and recent advances have made automated organoid segmentation from such images increasingly attainable. Yet existing tools largely leave morphological characterization, quality assessment, and comparisons between conditions to manual or ad hoc analysis. Here we present Organotchi, an open-source tool that integrates automated segmentation with longitudinal morphological analysis of neural organoids. Organotchi quantifies ten morphological features, including area, perimeter, and eccentricity, and tracks cystic structures over time, reports variability within and between batches, and flags outlier organoids and segmentation failures, supporting objective organoid characterization and enhancing downstream analysis. As a proof of concept, we apply Organotchi to disease modelling, pharmacological perturbation, and protocol optimization in neural organoids. One use case assesses drug response in breast cancer spheroids, demonstrating its use beyond its development domain.